| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 20/Feb/1997 | 25/Oct/2006 | Canada | Ontario | |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Genomics-Based Treatments for Osteoarthritis
| Molecular Diagnostics for cancer, CNS, Cardio Vacular diseases and arthritis
|
|
| *Research and Development of Pharmaceutical Products
| (not available)
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *CDG | *ChondroGene Limited | TSX Venture | DELIST |
| *YDG | *ChondroGene Limited | TSX Venture | DELIST |
| *YDG.RT | *ChondroGene Limited rt 15Ja02 | TSX Venture | DELIST |
|
|
| Name History | From | To |
| *ChondroGene Limited | 1/May/2000 | 25/Oct/2006 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2006 CFR | 29/Mar/2006 |
|
|
|
|
|
